← Leaderboards
Amy E Moran
Oregon Health & Science University
$3,321,643
Attributed
$4,384,181
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,384,181 · 3
By mechanism
R37$2,692,281 · 1
R01$1,299,526 · 1
R21$392,374 · 1
Top collaborators
- Luiz Eduardo Bertassoni2 shared
- Jason Michael Ridlon2 shared
- Karen Sandell Sfanos2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Nathalie Pamir$4,494,706
- Zheng David Qian$4,913,102
- Chad Cameron Hagen$927,474
- Tamara Hayes$429,862
- Paul Kievit$12,790,994
Others in their field
Other Emerging Leaders on “Malignant Neoplasm Of Prostate”
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Greg Yothers · University Of Chicago$35,003,821
- Lynn Briscoe · Leidos Biomedical Research, Inc.$30,044,343
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
- Himisha Beltran · Dana-Farber Cancer Inst$8,786,271
- John Freymann · Leidos Biomedical Research, Inc.$8,749,308
Research focus
Malignant Neoplasm Of ProstateTumorCellsMalignant NeoplasmsMediatingCancer ModelCastrationCancer PatientMaleImmunosuppressionImmunotherapyAndrogen ReceptorLeukocytesAndrogensCancer EtiologyComplexCell PhysiologyClinical TrialsAndrogen Deprivation TherapyExperimental StudyGenesImmune Checkpoint BlockadeCessation Of LifeEffectiveness
Grant awards (9)
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer$644,763
R01 · FY2025 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction$544,635
R37 · FY2025 · CA · contact PI
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer$654,763
R01 · FY2024 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction$520,926
R37 · FY2024 · CA · contact PI
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction$533,743
R37 · FY2023 · CA · contact PI
An organ-on-a-chip model system to study prostate cancer metastasis into vascularized bone$176,389
R21 · FY2023 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction$544,635
R37 · FY2022 · CA · contact PI
An organ-on-a-chip model system to study prostate cancer metastasis into vascularized bone$215,985
R21 · FY2022 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction$548,342
R37 · FY2021 · CA · contact PI